相关实验视频
Updated: May 5, 2026

10:24
Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons
Published on: August 29, 2014
84.8K
开发和验证长链脂肪酸氧化障碍的临床严重性得分,使用来自加拿大的现实世界证据
Randa Sultan1, Anastasia Ambrose1, Shalini Bahl2
1Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Molecular genetics and metabolism
|March 11, 2026
概括
这项研究创建了一个真实世界的数据库,并对线粒体长链脂肪酸氧化 (LC-FAO) 障碍进行了验证的临床严重性评分. 这一分数有助于分层患者,并可以改善LC-FAO的精密疗法.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 线粒体长链脂肪酸氧化 (LC-FAO) 障碍是一种罕见的遗传代谢状况.
- 由于LC-FAO疾病的发病率较低 (约为1:10,000),前性自然史研究具有挑战性.
- 现实世界的数据 (RWD) 和现实世界的证据 (RWE) 对于理解这些罕见疾病至关重要.
研究的目的:
- 为了生成LC-FAO障碍的RWD.
- 开发和验证LC-FAO疾病的临床严重性评分.
- 根据疾病严重程度对LC-FAO疾病患者进行分层.
主要方法:
- 创建了一个RWD,包括38名患有各种LC-FAO缺陷的患者.
- 一个临床严重性得分由四个独立的评价者在14名患者身上开发和验证.
- 评估了评估者之间的可靠性,并使用k-means聚类来对患者进行分层.
主要成果:
- 该RWD包括患有VLCAD,LCHAD,CACT,MAD,CPT-I,CPT-II和CT缺陷的患者.
- 临床严重性得分在诊断时 (ICC3k=0.979) 和治疗期间 (ICC3k=0.942) 显示出优异的评估者间可靠性.
- 患者被分为轻度 (0-8),中度 (9-14),严重 (≥15) 类别,诊断时得分明显高于对照组 (p<0.0001).
结论:
- 该研究通过RWD和验证的临床严重性得分为LC-FAO疾病提供了宝贵的RWE.
- 验证的得分具有实际的临床应用,可以帮助开发LC-FAO的精密疗法.
- 建议对临床严重性得分与更大的患者队列进行进一步验证,以提高其在管理LC-FAO中的有用性.
更多相关视频
相关概念视频
Overview of Fatty Acid Metabolism
25.4K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
25.4K
Chronic Pancreatitis II: Collaborative Care
563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
563
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764

